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Abstract
Gene Set Enrichment Analysis (GSEA) and its variations aim to discover collections
of genes that show moderate but coordinated differences in expression. However, such
techniques may be ineffective if many individual genes in a phenotype-related gene set
have weak discriminative power. A potential solution is to search for combinations of
genes that are highly differentiating even when individual genes are not. Although such
techniques have been developed, these approaches have not been used with GSEA to
any significant degree because of the large number of potential gene combinations and
the heterogeneity of measures that assess the differentiation provided by gene groups
of different sizes.
To integrate the search for differentiating gene combinations and GSEA, we propose
a general framework with two key components: (A) a procedure that reduces the
number of scores to be handled by GSEA to the number of genes by summarizing
the scores of the gene combinations involving a particular gene in a single score, and
(B) a procedure to integrate the heterogeneous scores from combinations of different
sizes and from different gene combination measures by mapping the scores to p-values.
Experiments on four gene expression data sets demonstrate that the integration of
GSEA and gene combination search can enhance the power of traditional GSEA by
discovering gene sets that include genes with weak individual differentiation but strong
joint discriminative power. Also, gene sets discovered by the integrative framework
share several common biological processes and improve the consistency of the results
among three lung cancer data sets.
∗Corresponding author; Supplementary material: http://vk.cs.umn.edu/ICG/
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1 Introduction
Microarray technology is an important tool to monitor gene-expression in bio-medical studies
[27]. A common experimental design is to compare two sets of samples with different pheno-
types, e.g. diseased and normal tissue, with the goal of discovering differentially expressed
genes [16]. Statistical testing procedures, such as such as the t-test and significance analysis
of microarrays [31], have been extensively studied and widely used. Subsequently, multiple
testing corrections are usually applied [11]. A comprehensive review of such approaches are
presented in [26].
Differential expression analysis based on univariate statistical tests has several well-known
limitations. First, due to the low sample size, high dimensionality and the noisy nature of
microarray data, individual genes may not meet the threshold for statistical significance after
a correction for multiple hypotheses testing [28]. Second, the lists of differentially expressed
genes discovered from different studies on the same phenotype have little overlap [28].
These limitations motivated the creation of Gene Set Enrichment Analysis GSEA [24, 28],
which discovers collections of genes, for example, known biological pathways [28], that show
moderate but coordinated differentiation. For example, Subramanian and Tamayo et al. [28]
report that the p53 hypoxial pathway contains many genes that show moderate differentia-
tion between two lung cancer sample groups with different phenotypes. Although the genes
in the pathway are not individually significant after multiple hypothesis correction [28], the
pathway is. For those familiar with GSEA and its output, Figure 1 shows the GSEA re-
sults for the p53 hypoxial pathway. GSEA also has the advantages of better interpretability
and better consistency between the results obtained by different studies on the same phe-
notype [28]. Ackermann and Strimmer presented a comprehensive review of different GSEA
variations in [1].
Unfortunately, GSEA and related techniques may be ineffective if many individual genes
in a phenotype-related gene set have weak discriminative power. A potential solution to
this problem is to search for combinations of genes that are highly differentiating even when
individual genes are not. For this approach, the targets are groups of genes that show
much stronger discriminative power when combined together [10]. For example, Figure 2(a)
illustrates one type of differentially expressed gene combination discovered in [10]. The two
genes have weak individual differentiation indicated by the overlapping class symbols on
both the two axes. In contrast, these two genes are highly discriminative in a joint manner
indicated by the different correlation structure in the two-dimensional plot, i.e. they are
correlated along the blue and red dashed line respectively in the triangle and circle class.
Such a joint differentiation may indicate that the interaction of the two genes is associated
with the phenotypes even though the two genes, individually, are not.
Figure 2(b) illustrates another type of phenotype-associated gene combination discovered
in [10], usually named differential coexpression [18, 12], in which the correlation of the two
genes are high in one class but much lower in the other class. As discussed in [10, 15],
existing multivariate tests such as Hotelling’s T 2 [23], Dempster’s T1 [9] are not suitable to
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Figure 1: A gene set (p53 hypoxial pathway) with many moderate but coordinated differ-
ential expression (towards the right tail of the ranked list). Figure generated with GSEA
software [28]
detect such ‘complementary’ gene combinations because they only screen for differences in
the multivariate mean vectors, and thus will favor pairs that consist of genes with strong
marginal effects by themselves but not the genes like the four in Fig. 2. For clarification,
we use differential gene combination search (denoted as DGCS) to refer to the multivariate
data analyses that are designed to detect the complementarity of different genes, rather
than those designed to model the correlation structure of different genes (such as Hotelling’s
T 2 and Dempster’s T1 test). A variety of other DGCS measures for complementary gene
combination search are proposed for gene pairs [20, 19] in addition to the two illustrated
in figure 2. Several measures are designed for higher-order gene combination beyond pairs
[12, 34]. These approaches can provide biological insights beyond univariate gene analysis
as shown in [10, 12, 34].
The limitations of GSEA and the capabilities of DGCS motivate a GSEA approach using
gene combinations in which the score of a gene set is based on both the scores of individual
genes in the set and the scores from the gene combinations in which these genes participate.
Unfortunately, gene combination techniques have not been used with the GSEA approach
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(a) M1 (b) M2
Figure 2: Two highly differential gene-pairs with weak individual discriminative power. Axes
indicate the expression level of indicated genes. Different color and shape of markers indicates the
two phenotypes. Figures modified from Dettling et al. [10]. This two types of differential gene
combinations are measured respectively by two measures M1 and M2 as described in section 2.
in any significant way because of two key challenges.
1. Finding a technique to reduce the vast number of gene combinations. There
are exponentially more gene combinations than individual genes, i.e. in addition to the
N univariate genes, there are N2 gene-pairs, N3 gene-triplets, etc. Many variations of
GSEA are based on a ranked list of the N individual genes as illustrated in Figure 1.
Including combinations in the ranked list might work for size-2 combinations [7, 35],
but would not be feasible for handling gene combinations of larger sizes. Furthermore,
this explosion in the number of gene combinations negatively impacts false discovery
rates. Thus, by adding so many gene combinations, we run the risk that neither groups
of genes nor individual genes will show statistically significant differentiation.
2. Combining results from the heterogeneous measures used to score different
size gene combinations. Furthermore, because a gene can be associated with the
phenotype either as an univariate variable or together with other genes as a combina-
tion, the importance of a gene set should be based on both the univariate gene scores
and the gene combination based scores of its set members. However, different measures
have a different nature, scale and significance, and thus are not directly comparable (to
be detailed in section 3.2). Indeed, differences exist even between gene combinations of
the same measure but of different sizes. Therefore, the challenge lies in how to design
a framework to combine different measures (a univariate measure1 plus one or more
1Ackermann and Strimmer [1] suggest that different univariate statistics have similar effect in GSEA and
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DGCS measures) together within the GSEA framework.
To the best of our knowledge, no existing work has sufficiently addressed these two chal-
lenges, although recent work presented in [7, 35] have made initial efforts at adding GSEA
capabilities to gene combination search. More specifically, two approaches are proposed in
[7, 35] to help the study of a specific type of size-2 differential combinations as illustrated
in 2(b). The experiments in these two studies provide some evidence about the benefits of
the integration. However, a more general framework is needed that can also handle other
types of size-2 differential combinations as illustrated in figure 2(a), higher order differen-
tial combinations (e.g. SDC[12] and the n-statistic [34]), and multiple types of differential
combinations.
Contributions: In this paper, we propose a general framework to address the above
challenges for the effective integration of DGCS and GSEA. Specific contributions are as
follows:
1. A gene-combination-to-gene score summarization procedure (procedure A)
that is designed to handle the exponentially increasing number of gene
combinations. First, for a given gene combination measure and a certain k, the score
of a size-k combination is partitioned into k equal parts which are assigned to each of
the k genes in the combination. Because each gene can participate in up to
(
N−1
k−1
)
size-k
combinations, each gene will be assigned with a score from each of these combinations.
Secondly, an aggregation statistic, e.g., maximum absolute value is used to summarize
the different scores for a gene. With such a procedure, scores for all the size-k gene
combinations are summarized to N scores for N genes. This procedure can effectively
retain the O(N) length of the ranked list while handling gene combinations of size-k
(k ≥ 2).
2. A score-to-pvalue transformation and summarization procedure (procedure
B) that is designed to integrate the scores contributed (in procedure A)
from different gene combination measures and from gene combinations of
different sizes. The transformation is based on p-values obtained from scores derived
from phenotype permutations. Such a transformation enables the comparison of scores
from different measures (either univariate or gene combination measures) and scores
from the gene combinations of different sizes. Subsequently, among all the p-values of
a gene, the best is used as an integrated score of statistical significance.
3. Integration of the above two procedures with GSEA More specifically, after
procedures A and B, each gene has a single integrated score. Unlike traditional uni-
variate scores, these N integrated scores are based on both the univariate statistic and
the gene combination measures. For the type of GSEA variations that depend on phe-
notype permutation test, P + 1 lists of N integrative scores are computed, one for the
thus, we consider only one univariate statistic rather than multiple of them.
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real class labels and the other for the P permutations. For the type of GSEA variations
that are based on gene-set permutation test, only the list of integrated scores for the
real class labels are needed. An independent Matlab implementation of the proposed
framework is available for download, which allows most existing GSEA frameworks [1]
to directly utilize the proposed framework to handle gene combinations with almost-
zero modification.
4. Experimental results that illustrate the effectiveness of the proposed frame-
work. We integrated three gene combination measures and the GSEA approach pre-
sented in [28] and produced experimental results from four gene expression datasets.
These results demonstrate that the integrative framework can discover gene sets that
would have been missed without the consideration of gene combinations. This in-
cludes statistically significant gene sets with moderate differential gene combinations
whose individual genes have very weak discriminative power. Thus, a gene combina-
tion assisted GSEA approach can improve traditional GSEA approaches by discovering
additional disease-associated gene sets. Indeed, the integrative approach also improve
traditional DGCS since most gene combinations are not statistically significant by
themselves. Furthermore, we also show that the biologically relevant gene sets dis-
covered by the integrative framework share several common biological processes and
improve the consistency of the results among the three lung cancer data sets.
Overview: The rest of the paper is organized as follow. In section 2, we describe three
gene combination measures used in the following discussion and experiments. In Section 3,
we present the technical details of the two procedures of the general integrative framework.
Experimental design and results are presented in Section 4, followed by conclusions and
discussions in Section 5.
2 Differential Gene Combination Measures
In this section, we describe three DGCS measures for use in the following discussion and
experiments. Let A =
{
a1, a2, . . . , a|A|
}
and B =
{
b1, b2, . . . , b|B|
}
be two phenotypic classes
of samples of size |A| and |B| respectively. For each sample in A and B, we have the ex-
pression value of N genes G = {G1, G2, . . . , GN}. First, we have the following two measures
(denoted as M1 and M2) defined for a pair of genes as presented in [10]:
M1(Gi, Gj) = corrA(Gi, Gj) + corrB(Gi, Gj)− corrA∪B(Gi, Gj) (1)
M2(Gi, Gj) = corrA(Gi, Gj)− corrB(Gi, Gj) (2)
where Gi and Gj are two genes, and corrD(Gi, Gj) represents the correlation of Gi and Gj
over the samples in set D. As discussed in [10], M1 and M2 can detect the joint differential
expression of two genes as illustrated in Figure 2(a) and Figure 2(b) respectively. M1 andM2
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are used as two representative measures for gene pairs. Other options for gene combination
measures for gene pairs have been investigated in [19, 20].
We use the subspace differential coexpression measure (denoted as M3) proposed in [12]
as the representative for measures for size-k gene combinations, where k can be any integer
(k ≥ 2).
M3(α) = RA(α) −RB(α) (3)
where α is a set of genes such that α ⊆ G and |α| = k. RA(α) and RB(α) respectively
represent the fraction of samples in A and B over which the genes in α are coexpressed. M3
is a generalization of M2 for detecting the differential coexpression of k genes (k ≥ 2), i.e.
the k genes are highly coexpressed over many samples in one class but over far fewer samples
in the other. Other options for size-k combinations include the n-statistic [34], SupMaxPair
[13], etc.
Signal-to-noise ratio (denoted asM0) is used as the representative of traditional univariate
statistics as in [28, 24].
M0(Gi) =
µA(Gi)− µB(Gi)
σA(Gi) + σB(Gi)
(4)
where µA(Gi) and µB(Gi) are the mean expression of Gi in class A and B respectively,
and σA(Gi) and σB(Gi) are the standard deviation of the expression of Gi in class A and B
respectively. Many other univariate statistics can be found in [1].
In this paper, these four measures are used as representatives of each category for the
illustration of the proposed integrative framework. However, the framework is general enough
to handle other measures from each of these categories.
3 Methods
In Section 1, we motivated the integration of DGCS with GSEA, discussed two challenges
associated with this integration, and briefly described two main procedures in the proposed
framework. In this section, we present the technical details of the two procedures and their
integration with GSEA.
3.1 Procedure A: combination-to-gene score reduction
There are two steps in procedure A. In step (1), for each DGCS measure and each size-k gene
combination, its score is divided into k equal parts and assigned to each of the k genes in the
combination. In step (2), the scores assigned to a gene from all the size-k combinations in
which the gene participates are summarized into a single score by an aggregation functions
such as max. Note that, for most univariate statistic and DGCS measures which can be
either positive or negative (e.g. the four measures described in section 2), the maximum
is taken over the absolute values of the scores, and the sign of the score with the highest
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absolute value is recorded for later use. Other simple statistics such as mean or median, or
sophisticated ones such as weighted summation [33] can also be used. Since the focus of this
paper is the overall integrative framework, we use max for simplicity.
We provide a conceptual example of procedure A for a gene G1 with a certain DGCS
measure M1. This example considers gene combinations up to size 4 for illustration purpose.
The gene is associated with scores assigned from gene combinations of size 2, 3 and 4 (denoted
as C2, C3 and C4 respectively) in which G1 participates. In step (2), the scores from C2, C3
and C4 are summarized by three maximum values, respectively. Please refer to the Appendix
section for the illustration of this example.
Procedure A serves as a general approach to summarize the
(
N
k
)
scores of all the size-k
combinations into N scores for the N genes. If we want to integrate GSEA with one DGCS
measure and a specific size-k, procedure A by itself can enable most existing variations of
GSEA to search, with almost-zero modification, for statistically significant gene sets with
moderate but coordinated gene combinations of size-k. Such a GSEA approach can col-
lectively consider the gene combinations affiliated with a gene set, and may provide better
statistical power and better interpretability for DGCS, as will be shown in the experiments.
3.2 Procedure B: Score-to-pvalue conversion and summarization
The hypothesis tested when one DGCS measure, say Mx, is integrated with GSEA (by pro-
cedure A) is that, whether a gene set includes significantly many genes with highly positive
(or highly negative) combination-based scores measured by Mx. An extended hypothesis
can be whether a gene set includes significantly many genes with highly positive (or highly
negative) scores, either univariate or combination-based scores measured by different DGCS
measures. The biological motivation of this extended hypothesis is that, a gene can be asso-
ciated with the phenotype either as an univariate variable or together with other genes as a
combination. To test this extended hypothesis, we design a second procedure (B) that can
integrate the scores of a gene from different measures.
Before describing the steps in this procedure. We first discuss in detail the challenges of
integrating heterogeneous scores from different DGCS measures and combinations of different
sizes.
1. The different nature of different measures: Different measures are designed to
capture different aspects of the discriminative power of a gene or a gene combination
between the two phenotypic classes. Signal-to-noise ratio (M0), a univariate gene-level
statistic, measures the difference between the means of the expression of a gene in the
two classes. In contrast, M2, a differential coexpression measure for a pair of genes
describes the difference of the correlations of a gene-pair in the two classes. Thus, for
a gene, the score of itself measured by M0 and the score assigned and summarized
from the
(
N−1
1
)
size-2 gene combinations measured by M2 are not directly comparable.
8
Similarly, the scores of different DGCS measures can also have a different nature, e.g.
M1 and M2 as illustrated in figure 2.
2. The different scales of different measures: Different measures also have different
ranges of values. For example, the range of M0, M1, M2, and M3 are [−∞,∞], [−3, 3],
[−2, 2] and [−1, 1] respectively. Thus, they are not directly comparable.
3. Differences in significance between different measures: Even after we normalize
the scores of different measures to a single range, say [−1, 1], they are still not com-
parable because the scores of different measures have different statistical significance.
For example, a normalized M0 score of 0.8 may be less significant than a normalized
M1 score of 0.5, if there are many genes with normalized M0 score greater than 0.8 in
the permutation test [28], but very few genes with normalized M1 score greater than
0.5 in the permutation test. Note that, such differences in statistical significance also
exists between gene combinations of different sizes, even for the same measure. Take
the subspace differential coexpression measure M3 as an example. A score of 0.5 for a
size-2 combination may not be as significant as a score of 0.5 for a size-3 combination
as discussed in [12].
To handle the above heterogeneity, we propose a score-to-pvalue transformation and sum-
marization procedure that can enable the comparison and integration of the scores of different
measures and combinations of different sizes. There are three major steps in procedure B.
3.2.1 Step 1: Score-to-pvalue transformation
Consider a concrete example. For a gene Gi and a measure M2, procedure A computes a
single summarized score. In this step, the original phenotype class labels are permutated say
1000 times, and for each permutation, the same procedure A is applied, and a corresponding
score for Gi and M2 is computed. We denote the score of Gi and M2 summarized with the
original label as Si,2,0, where i is the gene index, and 2 indicates the measure and 0 means
it is the score based on the original label. Similarly, we denote the scores computed in each
of the permutation as Si,2,j, where 1 ≤ j ≤ 1000.
These 1001 scores are organized in the table on the left in figure 3. The 1000 scores
computed in the 1000 permutations can be considered as the null-distribution for gene Gi
and measureM2, and a p-value can be estimated for Si,2,0. Specifically, if Si,2,0 is positive, the
p-value is the ratio of the number of scores that are greater or equal to Si,2,0 and the number
of scores that are positive. Similarly if Si,2,0 is negative, the p-value is computed as the ratio
of the number of scores which are less or equal to Si,2,0 and the number of scores which
are negative.2 Note that, such a score-to-pvalue transformation is done for both Si,2,0 and
each of Si,2,j (1 ≤ j ≤ 1000), if the GSEA approach to be integrated is based on phenotype
2Treating positive and negative scores separately follows the practice of GSEA [30]
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Figure 3: Illustration of step 1 in procedure B (score-to-pvalue transformation) for gene Gi
and measure M2.
permutation test [30]. Otherwise, only Si,2,0 needs to be transformed to p-value and will be
used by the GSEA approaches that are based on gene-set permutation [30]. In this paper,
we illustrate the proposed framework using the GSEA approach presented by Subramanian
and Tamayo et al. [28] which is based on phenotype permutation test.
Essentially, step 1 transforms the heterogeneous scores of a gene measured by different
measures into their corresponding significance values, which are comparable to each other
although their original values are not.
3.2.2 Step 2: P-value Summarization
Suppose that there are Q different measures to be integrated, one of which is a univariate
statistic, and the others are different DGCS measures for which we consider combinations
of sizes up to K. After step 1, each gene has a p-value for the univariate measure and up to
K p-values for each size of gene combination for each measure. In step 2, the best3 p-value
associated with a gene is selected as the integrated significance.
Essentially, procedure B integrates the scores of different DGCS measures for a gene
and the univariate statistic of the gene into a single p-value. Such a statistical significance-
3”Best” means it is the lowest raw p-value or the highest −log10 transformed p-value
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based integration of heterogeneous scores enables the comparison and thus the ranking of all
the N genes. However, this ranked list does not maintain the original directionality of the
integrated scores of each gene. In particular, most univariate statistics and DGCS measures
(e.g. all the four measures described in section 2) can be either positive or negative. Such
directionality information is lost in step 1 and 2 because the p-value is non-negative. Next,
we describe a third step to maintain the directionality in the integration.
3.2.3 Step 3: Maintaining directionality associated with the integrated p-values
In the simple case, the measures to be integrated capture the same type of differentiation
between the two phenotype classes, e.g. M2 and M3. Suppose there are two genes Gi and
Gj, whose integrated p-values are transformed respectively from two scores measured by M2
and M3 in step 2. The signs of these two scores are comparable to each other, because both
M2 and M3 capture the change of coexpression of a combination of genes. Thus, we simply
use the signs of these two scores as the signs associated with the integrated p-values of Gi
and Gj . Similarly, we associate a sign to all the N integrated p-values. And these N p-values
with associated signs can be used to rank the N genes based on their significance as well as
their direction of differentiation, i.e. p-values associated with positive signs are ranked with
descending significance, and afterwards, p-values associated with negative signs are ranked
with increasing significance.
In the other case, if the measures to be integrated capture different types of differentiation
between the two phenotype classes, the directionality can not be fully maintained. For
example, suppose there are two genes Gi and Gj , whose integrated p-values are transformed
respectively from two scores measured byM0 andM2 in step 2. The signs of these two scores
are not comparable, because M0 captures the change of mean expression, and M2 captures
the change of coexpression of a combination of genes. Specifically, up-regulation of Gi can
be associated with either high or low coexpression of another gene-combination in which
Gj participates. Thus, it is not reasonable to follow the same strategy to associate signs
to the N integrated p-values. If we know the correspondence of the signs of different genes
in advance, e.g. the up-regulation of G1 is associated with the low coexpression of G2 and
G3, then the signs can be maintained. However, because it is not realistic to assume such
prior knowledge, we propose the following heuristic approach which has proved a workable
solution for our initial experiments. Specifically, since the focus of step B is to integrate
different DGCS measures in addition to the univariate statistic M0, we considered M0 as
the base measure. For the integrated p-values that are transformed from scores measured
by M0 in step 2 (say there are w of them), we use the signs of these w M0 scores for the w
integrated p-values. For the signs of the other N − w genes, we assign positive signs to all
of them once and negative signs to all of them a second time. Correspondingly, we have two
ranked lists similar to the simple case described above.
Note that, if the directionality of differential measures can be preserved, the power of
this approach will be enhanced. To deal with the situation where signs are not comparable,
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other approaches will be explored.
3.3 Integration with GSEA
From the above description of procedure A and B, we know that, if only one DGCS measure
is used in the GSEA framework, only procedure A is needed. If one or multiple DGCS
measures are integrated together with the univariate statistic M0 in the GSEA framework,
procedure B is needed in addition. In the first case, the integrative framework outputs
a ranked list of N scores with associated signs for the original class label, and 1000 lists
corresponding to the 1000 permutation tests. In the second case, we have two sets of 1001
lists respectively for the two rounds of maintaining directionality in step 3 in procedure B.
In either case, the 1001 ranked lists along with the appropriate parameter settings and
specification of gene sets can be used to run GSEA. The only modification to GSEA is the
elimination of the initial GSEA step to generate the scores, simulated and actual, that mea-
sure the level of differentiation between genes across different phenotypes. The proposed inte-
grative framework is implemented as a Matlab function (available at http://vk.cs.umn.edu/ICG/),
independently from the GSEA framework to be integrated in this paper [28]. As summarized
by Ackermann and Strimmer [1], hundreds of variations of GSEA are being used by differ-
ent research groups. This independently implemented integrative framework can be easily
applied to other variations of GSEA.
3.4 A further technical detail
In our experiments, in order to have a fair comparison, we transform the 1001 ranked lists into
the exact sample distribution as the original lists corresponding to M0⊕GSEA. Specifically,
we only use the ranking information in the 1001 integrated ranked lists and map to them
to the values in the original lists based on M0⊕GSEA. Essentially, the values in the ranked
list passed to the GSEA framework are exactly the same among M0⊕GSEA, M01⊕GSEA,
M02⊕GSEA, M03⊕GSEA and M0123⊕GSEA, while the only difference is that the N genes
have different ranks in the lists. Such a mapping ensures that the additionally discovered gene
sets are because of the integration of gene-combinations in addition to univariate statistic,
rather than simply the different value distributions in the 1001 lists.
4 Results
In this section, we present the experimental design and results for the evaluation of the
proposed integrative framework. We first provide a brief description of the data sets and
parameters used in the experiments. Second, we describe and discuss the comparative ex-
periments to study whether the integration of DGCS and GSEA (denoted as DGCS⊕GSEA)
improves both DGCS and GSEA. The two major evaluation criteria are the statistical power
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Boston Michigan Stanford P53
M1 0 2 0 0
M2 645 1 2 1
M3 10 1 0 0
Table 1: Number of gene combinations with FDR less than 0.25 discovered from the four
data sets by each combination measure
to discover (additional) significant results, and the consistency of the results across different
datasets for the study of the same phenotype classes.
4.1 Data sets
The four datasets used in the experiments are described as follows:
1. Three lung cancer datasets respectively denoted as Boston [4], Michigan [3] and Stand-
ford [14]: all the three data sets consist of gene-expression profiles in tumor samples
from respectively 62, 86 and 24 patients with lung adenocarcinomas and provide clini-
cal outcomes (classified as ”good” or ”poor” outcome). The two phenotypic classes in
these three datasets are denoted as A and D as in [28].
2. A data set from the NCI-60 collection of cancer cell lines for the study of p53 status [25]
(denoted as P53 data set): the mutational status of the p53 gene has been reported
for 50 of the NCI-60 cell lines, with 17 being classified as normal and 33 as carrying
mutations in the gene. The two phenotypic classes in this dataset are denoted asMUT
and WT as in [28].
All four datasets were downloaded from the GSEA website4[28], and were already pre-
processed as described in the supplementary file of [28]. For all four data sets, we use the
gene sets from C2 in MSigDB
4 as in [28], as well as the same parameters.
4.2 Differential gene-combination measures
We consider one univariate statistic (M0), and three gene-combination measures (M1, M2
and M3) in our experiments. These four measures are described in section 2. M1 and M2
are defined only for size-2 combinations. For M3, we considered gene-combinations of size-2
and size-3 for the illustration of concept.
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Boston Michigan Stanford P53
M1⊕GSEA 4
(A) 1(A) 4(A) 13(PX)
M2⊕GSEA 1
(H) 7(HS) 4(HS) 0
M3⊕GSEA 0 1
(I) 3(X) 2(P )
Table 2: Number of gene sets with FDR less than 0.25 discovered from the four datasets by
integrating GSEA with each of the three combination measures. One or multiple biological
process(es) are indicated as superscript, from which we can observe the consistency across
three lung cancer data sets. A: apoptosis related pathways; H : responses to hypoxia; S:
sppaPathway ; I: insulin-signaling sets; X : oxidative-phosphorylation related sets; P : p53-
related sets. The names of the discovered gene sets and their FDRs are available in the
Appendix section.
4.3 Q1: Does GSEA-assisted DGCS improve traditional DGCS?
In this section, we study whether the question (Q1) of whether integration of DGCS and
GSEA can improve traditional DGCS. For this comparison, we consider the integration
of DGCS and GSEA as a GSEA-assisted DGCS approach. We first apply the traditional
DGCS approaches on the four datasets to find statistically significant gene-combinations. We
denote the three DGCS approaches respectively with the names of the three measures, i.e.
M1, M2 and M3. Second, we apply the integrative framework, in which GSEA is integrated
respectively with the three DGCS measures, to find statistically significant gene sets with
moderate but coordinated differential gene-combinations. We denote the three instances
of the integrative approach respectively as M1⊕GSEA, M2⊕GSEA and M3⊕GSEA. Then,
we compare the results of M1, M2 and M3, respectively with the results of M1⊕GSEA,
M2⊕GSEA and M3⊕GSEA.
In this section, we study whether the question (Q1) of whether integration of DGCS
and GSEA can improve traditional DGCS. For this comparison, we consider the integration
of DGCS and GSEA as a GSEA-assisted DGCS approach. We first apply the traditional
DGCS approaches on the four datasets to find statistically significant gene-combinations. We
denote the three DGCS approaches respectively with the names of the three measures, i.e.
M1, M2 and M3. Second, we apply the integrative framework, in which GSEA is integrated
respectively with the three DGCS measures, to find statistically significant gene sets with
moderate but coordinated differential gene-combinations. We denote the three instances
of the integrative approach respectively as M1⊕GSEA, M2⊕GSEA and M3⊕GSEA. Then,
we compare the results of M1, M2 and M3, respectively with the results of M1⊕GSEA,
M2⊕GSEA and M3⊕GSEA.
Table 1 lists the number of statistically significant gene combinations discovered respec-
tively by the three measures on each of the four datasets, with an FDR threshold of 0.25.
Table 1 lists the number of statistically significant gene sets discovered by integrating GSEA
4http://www.broadinstitute.org/gsea/
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respectively with the three DGCS measures on each of the four datasets, also with the same
FDR threshold of 0.25. Three major observations can be made by comparing the two tables:
4.3.1 GSEA-assisted DGCS has better statistical power than traditional DGCS
Table 1 shows that, in most cases, traditional DGCS discovers very few (less than 3) statisti-
cally significant gene combinations (althoughM2 andM3 have 645 and 10 gene-combinations
on the Boston data set, none of them have FDR lower than 0.10). In contrast, table 2 shows
that the integration of GSEA with the three combination measures discover multiple signif-
icant gene sets in most of the cases. This difference implies that the discovered statistically
significant gene sets include many moderate but coordinated differential gene combinations,
even though the combinations are not significant by themselves as shown in table 1. This
comparison demonstrates that traditional DGCS, similar to univariate gene analysis, has
limited statistical power, and DGCS⊕GSEA can increase that power.
4.3.2 GSEA-assisted DGCS has better result consistency than traditional DGCS
We further compare DGCS and DGCS⊕GSEA by studying the consistency of their results
on the first three data sets that are all from lung cancer studies, as done in [28]. For DGCS,
M1 discovered 2 genes on Michigan but nothing from Boston and Stanford; M2 discovered
645 combinations on Boston but only 1 and 2 from Michigan and Stanford, respectively,
and there are no common ones between the 645, 1, and 2 gene combinations; M3 discovered
10 genes on Boston but only 1 gene on Michigan and nothing from Stanford, and the 10
and 1 combinations do not overlap. The inconsistent results make the follow-up biological
interpretation very difficult.
In contrast, when the three DGCS measures are integrated with GSEA, several consis-
tent themes can be observed: (i) Apoptosis related pathways (marked by A in table 2):
M1⊕GSEA discovered four gene sets on Boston, three of which are known to be closely
related to cancer and specifically to apoptosis, i.e. nfkbpathway, ST-Gaq-Pathway and TNF-
Pathway. This apoptosis theme is shared by the gene sets discovered by M1-GSEA from
Michigan and Stanford, i.e. Monocyte-AD-Pathway, hivnefPathway, deathPathway and cas-
pasePathway. These apoptosis related pathways are enriched with the lung cancer samples
with good outcome, which makes sense biologically and also corresponds to the proliferation
theme supported by the gene sets enriched with the samples with poor outcome as reported
in [28]. Several other examples of the result consistency, as indicated by other superscripts in
Table 2, are in the technical report. This comparison demonstrates that traditional DGCS,
like univariate gene analysis, has poor result consistency across the three lung cancer data
sets, and DGCS⊕GSEA can improve its consistency by integrating DGCS measures with
GSEA.
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4.3.3 GSEA-assisted DGCS with different DGCS measures complement each
other
The number of significant gene sets discovered by the three versions of GSEA varies, i.e.
M1⊕GSEA and M2⊕GSEA discovered a bit larger number of significant gene sets than
M3⊕GSEA. However, M3⊕GSEA still discovered several gene sets that are not discovered
by M1⊕GSEA or M2⊕GSEA, e.g. one gene set from the Michigan data set and three from
the Stanford data set. This indicates that M1⊕GSEA, M2⊕GSEA and M3⊕GSEA have
complementary perspectives, i.e. different combination measures capture different aspects of
the difference between the phenotype classes (recall the two types of combinations in Figure
2). This also demonstrates the proposed framework is general enough to integrate any type
of DGCS with GSEA.
4.4 Q2: Does DGCS-assisted GSEA improve GSEA?
In this Section, we want to answer the question (Q2) of whether the integration of DGCS and
GSEA can improve traditional GSEA. For this comparison, we consider the integration of
DGCS and GSEA as a DGCS-assisted GSEA approach. We design three sets of comparisons.
Firstly, we compare the traditional univariate-statistic based GSEA (denoted asM0⊕GSEA)
with the integrative framework where one gene-combinations measure is used instead of
M0. Specifically, we compare the gene sets discovered by M0⊕GSEA with the gene sets
discovered by M1⊕GSEA, M2⊕GSEA and M3⊕GSEA. Then, we compare M0⊕GSEA with
the integrative framework where one gene-combinations measure is used in addition to M0,
i.e. M01⊕GSEA, M02⊕GSEA and M03⊕GSEA. Furthermore, we also study the integration
of multiple gene-combinations measure in addition to M0, e.g. M0123⊕GSEA.
Figure 4 displays the statistically significant gene sets discovered with different (combi-
nations of) measures respectively from the four datasets. An FDR threshold of 0.25 is used
as in [28] for comparison purpose. The results presented in [28] are exactly reproduced,
i.e. the gene sets listed in the rows corresponding to M0⊕GSEA. In each of these four fig-
ures, we consider the traditional univariate-statistic based GSEA (M0⊕GSEA) as the base-
line, and compare it with the rows corresponding to M1⊕GSEA, M2⊕GSEA, M3⊕GSEA,
M01⊕GSEA, M02⊕GSEA, M03⊕GSEA and M0,1,2,3⊕GSEA. From these comparisons, the
following observations can be made.
4.4.1 DGCS-assisted GSEA discovers additional significant gene sets
First, we compare the rows corresponding to M1⊕GSEA, M2⊕GSEA, M3⊕GSEA with the
rows corresponding to M0⊕GSEA. We bolded the additional gene sets that are only discov-
ered by M1⊕GSEA,M2⊕GSEA, M3⊕GSEA. For example, with M0⊕GSEA, no statistically
significant gene sets have been enriched with class A in the Boston data set. In contrast,
M1⊕GSEA discovered 4 gene sets, three out of which (discussed in Q1) are related to apop-
tosis which is consistent with the results on Michigan and Stanford. On the Michigan
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dataset, M2⊕GSEA discovered a gene set beta-Alanine-metabolism that is not discovered by
M0⊕GSEA. This gene set is related to the responses of hypoxia, which is consistent with
the results on Boston and Stanford. It is worth noting that, although most studies did not
report statistically significant gene sets on the Stanford dataset due to the very small sample
size, M1⊕GSEA, M2⊕GSEA, M3⊕GSEA respectively discovered 4, 4 and 3 significant gene
sets. These additional gene sets were discovered because the three DGCS measures capture
different types of the differentiation between the two phenotype classes, compared to the
traditional univariate differential expression-based GSEA.
Second, we compare the rows corresponding to M01⊕GSEA, M02⊕GSEA, M03⊕GSEA
with the rows corresponding to M0⊕GSEA. We bolded the additional gene sets that are
only discovered by the integrative approach. For example, on the Boston data set, M0 based
GSEA discovered 8 gene sets. In addition, M01⊕GSEA discovered the proteasomePathway
gene set, and M02⊕GSEA discovered the p53-signaling gene set. Both ubiquitin-proteasome
pathway and p53-signaling pathway are well-known cancer-related pathways that are also
specifically related to lung cancer [21, 6]. (Additional examples are in the technical report.)
The gene sets that are discovered by DGCS-assisted GSEA but not by M0-GSEA illustrate
the benefits of using DGCS to assist GSEA.
Next, we also observed that integrating multiple DGCS measures can further discover
statistically significant gene sets. For illustration purpose, we compare the rows correspond-
ing toM01⊕GSEA,M02⊕GSEA,M03⊕GSEA with the rows corresponding toM0123⊕GSEA.
M0123⊕GSEA discovers the g2Pathway gene set and the gsk3Pathway gene set, respectively
from the Boston and the Michigan dataset. Neither of these two pathways are discovered
byM0⊕GSEA, M01⊕GSEA,M02⊕GSEA andM03⊕GSEA. The curated gene set g2Pathway
contains the genes related to the G2/M transition, which is shown to be regulated by p53
[29], a well-known cancer-related gene. The curated gene set gsk3Pathway is the signaling
pathway of GSK-3-β, which has been shown to be related to different types of cancer[5, 22].
These two cancer-related pathways are discovered by M0123⊕GSEA but not by M0⊕GSEA,
M01⊕GSEA, M02⊕GSEA and M03⊕GSEA. This indicates that different members of these
two pathways are differential between the two phenotype groups in different manners, i.e.
the differentiation of some genes is captured by M0, some by M1, some by M2 and some by
M3. These two pathways can be discovered to be statistically significant only when these
measures are used together in the integrative framework. This demonstrates the benefits of
the proposed framework for integrating multiple DGCS measures with a univariate measure.
It is worth noting that, the gene sets discovered by the integrative framework with multi-
ple measures are not necessarily a superset of those discovered by integrating each individual
measure with GSEA since, when different DGCS measures are integrated with GSEA, the
null-hypotheses tested in the GSEA framework are correspondingly different. The highlight
of the integrative framework is that, additional gene sets can be discovered when differ-
ent DGCS measures are used to assist the traditional univariate statistic-based GSEA. In
practice, these different versions of GSEA should be used collectively.
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4.4.2 DGCS-assisted GSEA discovers gene sets with lower FDRs
:
Even when a gene set is discovered both before and after a DGCS measure is integrated
into the framework, we can observe several interesting cases where the FDR of a gene set
becomes much lower after the integration. We bolded the FDRs that significantly decreased
when they are discovered by the integrative approach. For example, M0123⊕-GSEA, in
which M0, M1, M2 and M3 are integrated together, discovers p53hypoxialPathway with an
much lower FDR of 0.00095, two-order lower than M0-GSEA. This example indicates that
several members of p53hypoxialPathway have weak individual differentiation measured by
M0, but have more significant differentiation when they are measured by M3. This and
other similar examples demonstrates the benefits of the proposed framework for integrating
multiple DGCS measures.
4.4.3 DGCS-assisted GSEA further improve the consistency across the three
lung cancer data sets
As presented in [28], M0⊕GSEA discovered 8 and 11 gene sets respectively from the Boston
and Michigan data sets, and 5 of the 8 in Boston and 6 of the 11 in Michigan are common.
The three unmatched gene sets that are discovered in Boston but not in Michigan are GLUT-
DOWN, LEU-DOWN and CellCycleCheckpoint. Interestingly, the latter two are discovered
from both the Boston and the Michigan data sets byM01⊕GSEA
5. Such observations suggest
that DGCS-assisted GSEA also provides new insights to the consistency between different
data sets.
4.4.4 Additional issues of multiple hypothesis testing
Because different combinations of measures are used in the integrative framework, addi-
tional issues of multiple hypothesis testing arise, even though multiple hypothesis test-
ing has been addressed for each measure via the phenotype permutation test procedure
in the GSEA framework proposed in [28]. To investigate this, we designed experiments
with 4 of the 15(= 24 − 1) possibilities of integrations, i.e. M01⊕GSEA, M02⊕GSEA,
M03⊕GSEA and M0123⊕GSEA. Even using a collective (meta-level) multiple hypothesis
correction, many discovered gene sets would still be significant. For examples, M0123⊕GSEA
discovers p53hypoxialPathway from the Boston data set with a low FDR of 0.00095, and
M0123⊕GSEA discovers deathPathway from the Michigan data set with a lower FDR of
0.00197. We also did additional permutation tests, in which we generate random gene sets
with the same sizes as the sets in MSigDB C2, and do the same set of experiments as shown
in Figure 4. The FDR values of the random gene sets computed in the integrative framework
are mostly insignificant (higher than 0.25).
5The CellCyclePathway discovered on Michigan and the cell-cycle-checkpoint discovered on Boston are
both cell-cycle related gene sets
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5 Discussion
In this paper we motivated the integration of differential gene-combination search and gene
set enrichment analysis for bi-directional benefits on both them. We proposed a general
integrative framework that can handle gene-combinations of different sizes (k ≥ 2) and
different gene-combination measures in addition to an univariate statistic used in traditional
GSEA. The experimental results demonstrated that, on one hand, GSEA-assisted DGCS
has better statistical power and result consistency than traditional DGCS. On the other
hand, DGCS-assisted GSEA can discover additional statistically significant gene sets that
are ignored by traditional GSEA and further improve the result consistency of the traditional
GSEA.
The proposed framework can be extended in several ways. Different variations of GSEA
will be considered. Along these lines, we note that the proposed integrative framework is
general enough to integrate most existing variations of GSEA approaches summarized in [1]
with minimal amount of modification. Also, it should be possible to integrate DGCS and
gene-subnetwork discovery. Both GSEA and gene-subnetwork discovery [17, 8] can discover
collections of genes, either known gene sets [28] or subnetworks in a molecular network (e.g.
protein interaction network), that show moderate but coordinated differentiation. In this
paper, we integrate DGCS and GSEA as an illustration of the general framework for inte-
grating scores from different gene-combination measures and gene-combinations of different
sizes, in addition to the traditional univariate statistic, but the same framework also ap-
plies to the integration of DGCS and gene subnetwork discovery. Another direction is the
use of this framework for the analysis of (GWAS) SNP data, by following the methodology
proposed in recently work on pathway/network based analysis of GWAS datasets [32, 2]. Fi-
nally, it may be possible to use constraints on gene-combinations to improve our framework.
In procedure A, for each gene-combination measure and an integer k, the score of a gene is
assigned from all the
(
N−1
k−1
)
possible gene-combinations. A further extension of procedure A
is to only consider the gene combinations, in which the k genes appear in a common gene
set, e.g. a pathway. Such gene-set-based constraints may better control false positive gene
combinations and improve the statistical power of the whole integrative framework.
6 Appendix
6.1 Illustration of procedure A
The illustration of procedure A is in figure 5.
6.2 Complete Gene-set Table
Due to the space limit, Table 2 and Figure 4 are both summarized from the four complete
tables that are available at http://vk.cs.umn.edu/ICG/. Specifically, Table 2 is a high-level
summary of the number of gene sets discovered and the biological processes associated with
each of the gene sets. In figure 4, we listed the complete results forM0⊕GSEA (the baseline),
while for the other rows, we only list a gene set if it is only discovered by the integrative
approach (with bolded name), or it has a non-trivially decreased FDR when it is discovered
by the integrative approach (with bolded FDR).
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Figure 4: Common captions for the four tables: Statistically significant gene sets
discovered by different (combinations of) measures from each of the four data sets. The
first row of each table shows the name of the data set, and the second row indicates the
two phenotype classes in the data set that a gene set can be enriched with. The first
column indicates the measures used in the integrative framework. For each data set and
each (combination of) measure(s), we list the names of the statistically significant gene sets
and the corresponding FDRs for both the classes. The traditional univariate-statistic based
GSEA (M0⊕GSEA) is considered as the baseline. For the other rows, we only list a gene
set if it is only discovered by the integrative approach (with bolded name), or it has a
non-trivially decreased FDR when it is discovered by the integrative approach (with bolded
FDR). Please refer to the Appendix section for the complete tables.
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Figure 5: Illustration of procedure A (combination-to-gene score assignment) for G1. The
three ellipses represent the three gene combinations that G1 participates to with respect to
measure M1.
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